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Summary
Background Primary health care (PHC) is a driving force for advancing towards universal health coverage (UHC). 
PHC-oriented health systems bring enormous benefits but require substantial financial investments. Here, we aim to 
present measures for PHC investments and project the associated resource needs.
Methods This modelling study analysed data from 67 low-income and middle-income countries (LMICs). Recognising 
the variation in PHC services among countries, we propose three measures for PHC, with different scope for included 
interventions and system strengthening. Measure 1 is centred on public health interventions and outpatient care; 
measure 2 adds general inpatient care; and measure 3 further adds cross-sectoral activities. Cost components included 
in each measure were based on the Declaration of Astana, informed by work delineating PHC within health accounts, 
and finalised through an expert and country validation meeting. We extracted the subset of PHC costs for each 
measure from WHO’s Sustainable Development Goal (SDG) price tag for the 67 LMICs, and projected the associated 
health impact. Estimates of financial resource need, health workforce, and outpatient visits are presented as PHC 
investment guide posts for LMICs.
Findings An estimated additional US$200–328 billion per year is required for the various measures of PHC from 
2020 to 2030. For measure 1, an additional $32 is needed per capita across the countries. Needs are greatest in low-
income countries where PHC spending per capita needs to increase from $25 to $65. Overall health workforces 
would need to increase from 5·6 workers per 1000 population to 6·7 per 1000 population, delivering an average of 
5·9 outpatient visits per capita per year. Increasing coverage of PHC interventions would avert an estimated 
60·1 million deaths and increase average life expectancy by 3·7 years. By 2030, these incremental PHC costs would 
be about 3·3% of projected gross domestic product (GDP; median 1·7%, range 0·1–20·2). In a business-as-usual 
financing scenario, 25 of 67 countries will have funding gaps in 2030. If funding for PHC was increased by 1–2% of 
GDP across all countries, as few as 16 countries would see a funding gap by 2030.
Interpretation The resources required to strengthen PHC vary across countries, depending on demographic trends, 
disease burden, and health system capacity. The proposed PHC investment guide posts advance discussions around 
the budgetary implications of strengthening PHC, including relevant system investment needs and achievable health 
outcomes. Preliminary findings suggest that low-income and lower-middle-income countries would need to at least 
double current spending on PHC to strengthen their systems and universally provide essential PHC services. 
Investing in PHC will bring substantial health benefits and build human capital. At country level, PHC interventions 
need to be explicitly identified, and plans should be made for how to most appropriately reorient the health system 
towards PHC as a key lever towards achieving UHC and the health-related SDGs.
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Introduction
Primary health care (PHC) is globally acknowledged as an 
essential driving force for advancing universal health 
coverage (UHC) and the 2030 Agenda for Sustainable 
Development.1 Investing in PHC yields high returns and 
promotes sustainability.2 Yet, only half of government 
spending in health across low-income and middle-income 
countries (LMICs) is currently allocated to primary care 
and public health interventions—ie, PHC services.3 
Ensuring quality PHC services should not be considered a 
low-cost strategy: investing in accessible health systems 
that provide a comprehensive set of interventions to all 
those in need can bring enormous benefits but will 
require significant financial investments. Among the 
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commitments made at the Global Conference on Primary 
Health Care in October, 2018, countries and other 
stakeholders pledged to ensure adequate financing of 
primary health care in the Declaration of Astana.4 The 
definition of how much is adequate is subject to debate.
Questions around spending targets for PHC have 
been debated for decades. In 1986, Patel5 suggested that 
advancing PHC across so-called developing countries 
would cost about 5% of gross domestic product (GDP). 
Because of the realisation that resources are constrained, 
some stakeholders opted for a more selective definition of 
PHC, emphasising a smaller set of highly cost-effective 
interventions.6 The past 10 years have seen a revitalisation 
of support for a broader PHC agenda, in line with the 
original commitments in the Declaration of Alma-Ata, 
and its importance in achieving the health-related 
Sustainable Develop ment Goals (SDGs). The Primary 
Health Care Performance Initiative was established in 
2015 to sup port measurement of PHC-related variables, 
with PHC expenditure per capita as one recommended 
indicator.7 Estimates of current PHC expenditure range 
between US$15 and $60 per capita in LMICs, depending 
on the definition applied.3 At the country level, 
information on current spending can be compared 
against needs-based targets and projected costs for 
expanding service delivery, to inform resource allocation 
decisions.
Global resource needs for the SDGs serve multiple 
purposes, including advancing our understanding of 
implementation strat egies or production functions, 
supporting resource mobilisation, and informing 
financing strategies.8 Global PHC costs were estimated in 
a 2018 study based on a defined set of services delivered 
through selected platforms that serve as first point of 
contact.9 Watkins and colleagues9 thus estimated that total 
annual costs of delivering PHC interventions in low-
income countries and lower-middle-income countries, at 
80% population coverage, would amount to $350 billion, 
or about $97 per capita (2016). However, their approach 
did not explicitly consider that different countries have 
different capacities for scale-up and did not provide 
details on the type of system investments needed.
To adequately plan and finance health systems, and 
in particular to strengthen their PHC orientation, 
Research in context
Evidence before this study
Although the role of primary health care (PHC) for health 
outcomes is widely acknowledged, substantial variation exists in 
health service models and packages among countries, and little 
work has been done to develop detailed definitions of what PHC 
encompasses. Similarly, as of yet, few global benchmarks have 
been proposed for health system investment to strengthen 
PHC. Several studies and initiatives have considered the resource 
implications of functioning PHC systems. For example, in 1986, 
Patel suggested that PHC costs across developing countries 
would amount to around 5% of gross domestic product, but 
also noted that PHC programmes are largely undefined in terms 
of their content. Although the policy debate and visibility of PHC 
has increased, the boundaries of PHC, as well as related 
budgetary needs, remain poorly conceptualised. The Primary 
Health Care Performance Initiative was established in 2015 to 
support measurement of PHC-related variables, with PHC 
expenditure per capita as one recommended indicator. Country 
scorecards were designed, with an intent to report current PHC 
expenditure using a standardised method but without 
identifying a target. At the global level, Watkins and colleagues 
estimated the total annual cost of providing essential PHC 
interventions across low-income countries and 
lower-middle-income countries at 80% population coverage to 
be about $350 billion, or about $97 per capita on average 
(in 2016 US$). Although global per capita estimates of service 
delivery are useful to provide a rough indication of spending 
needs, countries also need guidance on system requirements to 
expand PHC. Therefore, our study takes an ingredients-based 
approach to be able to identify the specific inputs needed to 
strengthen PHC across different country contexts.
Added value of this study
To the best of our knowledge we develop here, for the first 
time, three measures that relate to investments to strengthen 
PHC-orientation in health systems, identifying both specific 
interventions and health systems requirements. The added 
value of our study is that we discuss different measures of PHC 
costs; we specify the inputs required to strengthen PHC delivery 
across countries and estimate costs using country-specific data; 
we present and discuss related investment guide posts; and we 
add to the evidence base on the potential impact to be brought 
by investments in PHC as well as the affordability of delivering 
high-quality PHC across different settings.
Implications of all the available evidence
Defined service packages, emphasising primary care and public 
health services, as well as multisectoral actions with an impact 
on health, help inform the health investment agenda in 
low-income and middle-income countries. The results provide 
evidence on the likely cost drivers within countries seeking to 
expand their health service coverage by strengthening PHC, and 
an estimate of additional resource needs. Impact modelling 
indicates that significant health gains can be achieved by 
investing in primary care and public health and confirms the 
catalytic role that PHC can play in the universal health care and 
Sustainable Development Goals agendas. Although all three 
measures presented here are important for operationalising 
PHC, countries can assess which measure is most relevant for 
their specific dialogue around investments and monitoring 
purposes, and use this information to drive context-appropriate 
investments along a continuum of comprehensive PHC.
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governments need information on the specific health 
system investments required. Here, we add to the global 
evidence base by drawing on the framework for WHO’s 
previously published price tag for the health SDG 
targets10 and specifically identifying investments 
required for PHC across the health system building 
blocks. By using an ingredients-based approach we can 
allow for differentiated coverage targets across different 
categories of countries and identify the cost drivers for 
accelerating PHC implementation. Explicitly defined 
measures for PHC investment needs can be used to 
advocate for increased budget allocations.
Methods
Study design
This modelling study was done using data from 67 LMICs 
(appendix p 2). Three measures of PHC costs were 
developed using a functional definition that focuses on 
the purpose of PHC interventions, rather than where, 
how, or by whom they are delivered or were developed. 
This approach is consistent with others in the literature, 
such as the methodology used by WHO to estimate 
current PHC expenditure, based on the system of health 
accounts, which uses a functional classification of 
services provided to monitor PHC expenditure.3 Another 
advantage of this approach is that the explicit definition 
of PHC interventions within a country’s essential service 
package can be aligned with the prin ciple of progressive 
realisation of UHC (ie, increasing access to an expanding 
PHC intervention package over time).11
Recognising the variation in PHC interventions among 
countries, we propose three measures of PHC, which 
represent a successive expansion of the scope of inter-
ventions (table 1). These three measures are consistent 
with global definitions of PHC as agreed at the Global 
Conference on Primary Health Care, which emphasised 
that the three components of PHC as primary care and 
essential public health functions are the core of integrated 
health services; multisectoral policies and actions; and 
empowered people and communities.4 Given the 
variation in health service models and intervention 
packages among countries, little work has been done to 
develop benchmarks for health system investment to 
strengthen PHC.12 Our proposed measures correlate with 
Measure 1: focus on preventive and outpatient care as 
the basis for PHC
Measure 2: expanded measure considering general 
inpatient care and supportive health systems
Measure 3: broader PHC measure including 
cross-sectoral investment
Description This measure centres on preventive and outpatient care. 
Preventive interventions incorporate public health 
interventions such as behaviour change, policy, and tax 
interventions when aimed at adjusting behaviour. 
Outpatient care is limited to non-specialist outpatient 
care services, using definitions commonly applied within 
a health accounts framework. This measure also includes 
a share of the required resources for information systems, 
good governance and financing.
This measure adds general inpatient care, orthopaedic 
devices, and prosthetics; full health sector cost for 
strengthening information systems, good 
governance, and financing; and the cost of health 
emergency preparedness (and compliance with the 
International Health Regulations).
This measure captures broader cross-sectoral 
investments important for advancing PHC, including 
investments in water, sanitation, and hygiene; 
indoor air pollution; and food safety. This measure also 
considers essential information-gathering functions, 
done only in part by the health sector, such as censuses 
and civil registry systems.
Rationale This measure is aligned with a common understanding 
that PHC primarily reflects first contact at lower 
(close-to-patient) levels of the health system and should 
focus on preventive care and general outpatient care; 
it thereby centres on the essential components of PHC in 
promoting preventive and close-to-client services
This measure captures a broader interpretation of the 
Alma-Ata declaration and considers skilled care at 
birth, which otherwise would not be covered under 
PHC; the boundaries for this measure remain limited 
to the health sector
This measure responds to the broad SDG agenda and 
the need to consider cross-sectoral investments as PHC 
is advanced in the 21st century; the boundaries are 
expanded beyond the health sector to include key 
cross-sectoral interventions
Consistency with 
expenditure 
monitoring
The measure is consistent with the health-care based 
approaches put forward by Van de Maele and colleagues3 
for monitoring PHC expenditure
This measure goes beyond current proposed 
approaches for monitoring expenditure on PHC, 
which do not include inpatient care when delivered in 
hospitals
This measure goes beyond current proposed approaches 
for monitoring expenditure on PHC using health 
accounts, which by necessity are limited to the health 
sector only
Health 
intervention 
components
Population-based interventions; generalised outpatient 
care; medicines, diagnostic tests, and supplies; 
programme support costs
Population-based interventions; generalised 
outpatient care; generalised inpatient care; medicines, 
diagnostic tests, and supplies; orthopaedic devices and 
prosthetics; programme support costs
Population-based interventions; generalised outpatient 
care; generalised inpatient care; medicines, diagnostic 
tests, and supplies; orthopaedic devices and prosthetics; 
programme support costs; conditional cash transfers for 
demand generation; cross-sectoral interventions 
(eg, water, sanitation, and hygiene; road safety; violence 
reduction; pollution control; and food safety)
Functional service 
delivery systems 
components
Health workforce salaries and in-service training; 
health facility infrastructure construction, refurbishing, 
and maintenance; medical equipment purchase and 
maintenance; logistics and supply chain
Health workforce salaries and in-service training; 
health facility infrastructure construction, 
refurbishing, and maintenance; medical equipment 
purchase and maintenance; logistics and supply chain
Health workforce salaries and in-service training; 
health facility infrastructure construction, refurbishing, 
and maintenance; medical equipment purchase and 
maintenance; logistics and supply chain
Governance, 
financing, 
and monitoring 
components
Governance (share 80%); financing (share 80%); 
health information systems (some components); and 
laboratory capacity
Governance (full 100%); financing (full 100%); 
health information systems; health emergency 
preparedness; emergency response
Governance (full 100%); financing (full 100%); 
health information systems in the health sector and 
beyond; health emergency preparedness; emergency 
response
PHC=primary health care. SDG=Sustainable Development Goal.
Table 1: Three proposed measures for PHC investment needs
See Online for appendix
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Measure 1 Measure 2 Measure 3
Health interventions
Number of health 
interventions considered 
as PHC (out of 
188 interventions in 
original SDG model)
143 152 160
Examples of interventions included under each PHC measure, by platform
Policy and 
population-wide 
interventions
Legislative and regulatory interventions such as taxes on alcohol and tobacco, 
marketing restrictions, and bans; population-level behaviour change 
communication campaigns—eg, breastfeeding for infants and safe sex to reduce 
HIV transmission
Same as M1 Same as M1, plus water, 
sanitation, and hygiene 
interventions
Periodic outreach and 
schedulable services
Vaccination programmes; family planning; nutrition counselling and micronutrient 
supplementation
Same as M1 Same as M1
First-level clinical 
services
Disease-specific pharmaceutical treatment through outpatient care (eg, oral 
antibiotics for pneumonia, first-line tuberculosis treatment, standard glycaemic 
control treatment for diabetes); counselling and support for behaviour change 
(eg, smoking cessation)
Same as M1, plus normal delivery and basic 
neonate resuscitation
Same as M2
Care provided at first 
level and above
Mammography to detect breast cancer; treatment of asthma and chronic 
obstructive pulmonary disease
Same as M1, plus basic emergency obstetric 
care
Same as M2
Health system strengthening
Health workforce Health workforce estimates are calculated for three categories: medical doctors, 
nurses or midwifes, and other. We use a bottom-up approach to estimate the 
full-time equivalent workers required to provide the defined package of PHC 
interventions, by country and by year. Bottom-up estimates were also calculated 
for the full SDG set of interventions and a relative share was subsequently 
estimated for PHC. The relative share was applied to the total number of health 
workers estimated to be required for the WHO SDG price tag, which was based on 
target population-density ratios. Using this approach, the estimated health worker 
cost for PHC is a proportion of the population-density-based cost as estimated in 
the SDG price tag.
Similar to M1, we calculate the share of health 
workers’ time spent delivering PHC 
interventions within the context of the overall 
SDG price tag; under M2, the share is greater, 
because it includes more interventions than 
M1. In order to account for generalised 
inpatient care, we include an additional share 
of health worker time.
Same as M2
Infrastructure and 
equipment
The model includes costs for health centres, district hospitals, and provincial 
hospitals. The full costs of building, refurbishing, and maintaining health centres is 
attributed to PHC. For district hospitals and provincial hospitals, we include a 
percentage share of the cost required to construct, refurbish, and equip. The share 
is derived from national health accounts expenditure data on non-specialised 
outpatient care in low-income and middle-income countries (33% for district 
hospitals and 3% for provincial hospitals).
Similar to M1, we include the full cost of health 
centres. We increase the share of costs 
allocated to PHC from district hospitals to 
81% to account for general (non-specialised) 
inpatient care, and similarly increase the share 
to 27% for provincial hospitals. Again, the 
shares are based on data from national health 
accounts.
Same as M2
Health information 
system
Costs for strengthening the health-facility-based system Costs include components related to 
strengthening the health-facility-based 
system, administrative information systems, 
public health institutes, and administration of 
surveys
Same as M2, plus the full cost 
for a census and civil registry 
system (includes costs 
beyond the health sector)
Medicines, diagnostics, 
and supplies
Costs are directly estimated based on medicines, diagnostics, and supplies required 
for each intervention, multiplied by the numbers reached by country and year
Same as M1, plus a greater cost because more 
interventions are included
Same as M2, plus considering 
a greater number of 
interventions
Supply chain The cost of supply chain was estimated by taking a share of the supply chain cost 
from the 2017 WHO SDG price tag; the share is based on the relative total cost of 
commodities provided under each PHC package, compared with the total cost of 
commodities estimated in the SDG price tag; costs for cold chain are estimated 
separately and included fully
Same as M1, plus considering the specific 
commodity costs for M2; cold chain is 
separate and included fully
Same as M2, plus considering 
the specific commodity costs 
for M3; cold chain is separate 
and included fully
Health financing 80% of health-financing-related costs are included The full health-financing costs are included Same as M2
Governance 80% of governance-related costs are included The full governance costs are included Same as M2
Emergency risk 
management or 
International Health 
Regulations
A share of laboratory costs at the district and provincial hospital level; the share 
applied is the same as for the infrastructure component
Same as M1, plus all costs for preparedness 
except poison control centres and national 
laboratories
Same as M2
Emergency relief (health 
worker hazard pay for 
working in distressed 
settings)
Included in their entirety Included in their entirety Included in their entirety
Facility reconstruction in 
post-conflict settings
Included in their entirety Included in their entirety Included in their entirety
(Table 2 continues on next page)
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the definitions used within the system of health accounts 
to differentiate between specialised and non-specialised 
(general) care health services.13 The list of interventions 
included in each measure was further informed by an 
expert meeting and country validation process.
Measure 1 includes preventive public health inter-
ventions and general outpatient services, and is thus 
largely consistent with the measure put forth for 
monitoring current expen diture as per the national 
health accounts framework.3 Measure 2 broadens the 
scope of interventions by including non-specialised 
inpatient services, including uncomplicated deliveries 
and immediate neonatal care; it also captures a broader 
range of costs related to supportive health systems 
and health security, including compliance with the 
international health regulations.14 Measure 3 goes further 
in capturing broader cross-sectoral investments that are 
important for health outcomes, such as water and 
sanitation, air quality improvements, road safety, and 
food safety, as well as broader health security (including 
animal health and zoonotic disease control). Specialised 
care, however, whether outpatient or inpatient, is 
excluded from all three measures. Cross-sectoral invest-
ments as included under measure 3—eg, investments 
to address respiratory, food-borne and water-borne dis-
eases—play a key role that has been clearly established in 
the literature, and roughly a quarter of global disease 
burden could be prevented by reducing environmental 
risks.15 Importantly, our measures delink interventions 
from the level of care, insofar as we include costs and 
effects for PHC interventions, even when they might be 
delivered at higher levels of care.
Applying PHC measures within a modelling framework
To apply these measures to an investment model, our 
starting point is WHO’s cost projections for reaching 
the health SDG targets, published in 2017.10 An explicitly 
defined set of essential health interventions (a health 
benefits package) and associated health system invest-
ments necessary to achieve the health-related SDGs 
were modelled to be scaled up from 2016 to 2030, across 
67 LMICs. Within the model, countries are assumed 
to invest over time according to the maturity of their 
system, thereby progressing at different speeds 
according to their current system strength and capacity. 
The WHO 2017 model was largely limited to the health 
sector (table 2).
The WHO SDG projection model was designed with a 
PHC-centred approach in mind—ie, the health workforce 
and infrastructure models were set up to accommodate a 
close-to-client health system, which makes it appro-
priate for our analysis. However, the model focuses on 
health sector investments, which limits the completeness 
of resource needs for measure 3, which go beyond 
the health sector. The original SDG model included 
188 specific health interventions. These were established 
either to be PHC interventions or not, according to their 
classification within the health accounts framework. All 
interventions delivered through population or outreach 
platforms were included in one or more PHC measures, 
as were most clinical services (appendix pp 7–18). Shared 
investments required across the health system were 
estimated for the different health system building blocks 
as defined by WHO. Here, we used a mix of methods, in 
which some allocation rules were adopted from the 
expenditure monitoring frame work (eg, governance-
related costs) and others were derived from the PHC-
relevant share of overall service delivery estimated within 
the WHO SDG projection model (eg, the share of health 
workforce and supply chain costs for PHC services as a 
share of the full modelled package of interventions). To 
the extent possible, health system investments are directly 
related to the package of interventions considered under 
each measure. Costs are estimated by country and by year 
using an ingredients-based approach—ie, breaking each 
investment down into a multiplication of quantities (by 
year) by prices, and using country-specific prices when 
available (appendix p 5).
The baseline year in our model is 2015, with 
investments scaled up successively until 2030. Our 
estimates are thus incremental to the assumed 2015 
investment levels, and we assume limited progress 
was made during 2015–19.16 Capital investment costs 
originally modelled for 2016–19 were redistributed to 
years 2020–30.
Here, we present incremental outputs for 2020–30. 
Similar to the previously published SDG projections, we 
present estimates for eight groups of countries: three 
income categories and five additional country categories 
representing different degrees of health system maturity 
For the WHO health systems 
strengthening glossary see 
https://www.who.int/
healthsystems/hss_glossary/en/
Measure 1 (M1) Measure 2 (M2) Measure 3 (M3)
(Continued from previous page)
Programme support 
costs
Included in their entirety for health sector Included in their entirety for health sector Included in their entirety for 
health sector plus additional 
costs for multisectoral HIV 
and AIDS interventions
Cash transfers to 
increase care seeking
Excluded Included specifically for skilled birth 
attendance
Same as M2 plus included for 
general health-care seeking
M1=measure 1. M2=measure 2. M3=measure 3. PHC=primary health care. SDG=Sustainable Development Goal.
Table 2: Applying the three PHC measures to WHO’s SDG price tag model
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(conflict, vulnerable, and health system strength 1, 2, 3; 
appendix p 4).
Projecting impact
For most interventions, estimates of health impact are 
projected using the impact models within the OneHealth 
Tool. The models include number of deaths prevented, 
stillbirths prevented, HIV infections, and prevention and 
treatment of non-communicable dis eases and mental 
health disorders resulting from expanding coverage of 
PHC interventions. For a few areas (tuberculosis, 
neglected tropical diseases [NTDs], and cervical cancer 
screening), impacts were estimated outside of the 
OneHealth Tool and added in manually. To project gains 
in life expectancy we developed standard life tables using 
the standard UN life table methods for the base year of 
2015 and the final year of 2030.17 For the life table input of 
number of deaths in 2030, we subtracted deaths avoided 
for tuberculosis, NTDs, and cervical cancer screening 
from the deaths calculated in the OneHealth Tool to 
estimate the total number of deaths by age and sex for 
each country included in the analysis. We then estimated 
life expectancy at birth for each country in 2030 and 
calculated the difference between 2030 and 2015. Healthy 
life-years gained are calculated by comparing the healthy 
years of life lived between the population in flatline 
projections (ie, unchanged coverage) and the PHC scale-
up scenarios. Health adjustments are made using the 
Global Burden of Disease disability weights for each 
health state modelled. In addition to those conditions 
modelled in the OneHealth Tool, we add healthy life-
years for tuberculosis,18 NTDs,19 and stillbirths avoided.10
Validation process
The approach to define PHC measures was discussed 
with country representatives and global health policy and 
modelling experts in a meeting in Geneva on Sept 24–27, 
2018. Participants included inter national experts and 
academics, as well as representatives from 12 LMICs 
whose population jointly accounts for more than 48% of 
the population in the 67 countries covered in the model. 
Country-specific data inputs used for the modelling were 
reviewed and validated by country par ticipants during 
the meeting, as well as through follow-up correspondence. 
Data were provided by country participants for the most 
recent year available.
Developing PHC investment guide posts
Investment guide posts are derived from our model for 
costs, outpatient visits, and health workforce. The 
estimates are generated by country-specific models but 
are aggregated and presented as average estimates by 
income level and country type. Guide posts are a partial 
measure, covering only the modelled interventions. 
Here, we present them as conceptual measures for future 
assessment and monitoring purposes.
Projected costs for PHC are presented as additional and 
total per capita estimates (panel). The additional amounts 
represent what is required to advance health service 
delivery beyond current levels of investment, assuming 
that current levels of investment remain at a constant level.
Projecting additional financing for PHC
We generate scenarios for expanding current health 
expenditure across all LMICs, considering three 
possible scenarios for growth in spending: business as 
usual (following the historical trend of each country); 
progress of 1% (achieving a 1% point increase in current 
health expenditure as a percentage of GDP), and an 
ambitious 2% (achieving a 2% point increase in current 
health expenditure as a percentage of GDP). To assess 
the potential financing gap, we calculated incremental 
costs and compared them with projected health 
spending and the share these costs would have of overall 
government expenditure and GDP in each country 
(appendix pp 37–42).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
Estimated additional investment needs for PHC range 
from $200 billion for measure 1 to $253 billion for 
Panel: Constructing investment guide posts for total 
primary health care (PHC) expenditure
Total PHC cost per capita is calculated as the sum of estimated 
current PHC expenditure plus the additional amount estimated 
through our analysis. Current PHC expenditure is estimated by 
applying option 5 from van de Maele and colleagues,3 which 
includes general outpatient care, medical goods, and a share of 
administration costs. Data on current spending was available 
from WHO’s global health expenditure database in 2016 US$ 
for 45 low-income and middle-income countries. We deflated 
estimates to 2014 US$ using country-specific price deflators. 
Results are presented as population-weighted average values 
by country group.
Expenditure estimates on PHC from health accounts only 
include recurrent expenditures, since expenditure on capital 
goods is reported separately within health accounts and no 
proposed methods exist for separating out the PHC share of 
capital investments.11 Therefore, our investment guide posts 
for total PHC expenditure per capita are underestimated, 
because current expenditure is limited to recurrent costs only. 
Given the important role of investment in health infrastructure 
and equipment to improve geographical accessibility and 
quality of care, we advocate for future measures to include 
more complete reporting on capital expenditure for PHC.
For WHO’s global health 
expenditure database see 
https://apps.who.int/nha/
database
For the OneHealth Tool see 
https://www.avenirhealth.org/
software-onehealth.php
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measure 2 and $328 billion for measure 3 per year from 
2020 to 2030 to expand service delivery to meet SDG 
health targets (table 3, figure 1; appendix p 46). To provide 
a first set of preventive interventions and outpatient 
services (measure 1), an additional $2215 billion is 
needed over the period 2020–30, with health workforce 
accounting for 31·1% and infrastruc ture for 27·1% of 
costs (figure 1). Five countries (China, India, Indonesia, 
Nigeria, and Pakistan) account for 49·1% of costs 
(appendix pp 47–48). An additional $32 is needed per 
capita across LMICs for capital and recurrent invest-
ments, of which $28 are recurrent (table 3). For 
measure 1, per-capita needs are greatest in low-income 
countries, where recurrent spending on PHC per capita 
needs to increase from $25 to $65 (additional $40) with 
an additional $8 per capita for capital investment.
Investment guide posts indicate that the health work-
force would need to increase from 5·6 per 1000 population 
to 6·7 per 1000 population by 2030, with an average of 
5·9 outpatient visits for PHC per capita per year. 
Estimates for workforce and visits differ across income 
groups because of differing starting points (existing 
numbers of health workers and patient contacts are 
higher in middle-income countries), to which we add the 
required numbers of workers and visits on the basis of 
country-specific epidemiology and coverage targets 
(ie, a high untreated non-communicable disease [NCD] 
prevalence in many middle-income countries increases 
the need for outpatient visits and workforce). Examining 
the incremental outpatient visits for modelled PHC 
interventions shows that the highest additional need is in 
low-income countries (4·0 per year).
Our projection model for financing indicates that if 
current trends continue, health expenditure across the 
67 countries would increase from an average of 5·6% of 
GDP in 2016 to reach 6·1% of GDP in 2020 and 6·6% of 
GDP in 2030. However, by 2030, incremental PHC costs 
for measure 1 would on average require 3·3% of projected 
GDP (median 1·7% range 0·1–20·2; appendix pp 40–41). 
In a business-as-usual scenario, the number of countries 
with funding gaps would be 25 of 67 in 2030 (figure 2). If 
funding for PHC was increased by 1–2% of GDP across 
Year Low-income 
countries
Lower-middle-income 
countries
Upper-middle-income 
countries
All 67 countries
Costs
Total additional cost (recurrent and 
capital; billion US$)
Sum 2020–30 396 960 858 2215
Annual additional cost (billion US$)
Recurrent and capital Average 2020–30 36 87 78 200
Recurrent only Average 2020-30 30 77 72 179
Current health expenditure per capita 2016 36 84 513 252
Current per capita PHC expenditure 
(recurrent only)*
2016 25 34 304 62
Additional PHC per capita cost (US$)
Recurrent and capital Average 2020–30 48 29 32 32
Recurrent only Average 2020–30 40 25 29 28
Total recurrent cost per capita for PHC 
(current per capita PHC expenditure plus 
additional PHC per capita cost; recurrent 
only; US$)
2030 65 59 334 90
Health workers
Total number of health workers, 
per 1000 population
Latest year available 1·4 4·6 7·9 5·6
Health workers needed for PHC services, 
per 1000 population
2030 5·9 6·0 8·1 6·7
Outpatient visits
Total outpatient visits for modelled PHC 
interventions, per year, per capita
2030 5·7 4·0 8·7 6·0
Incremental outpatient visits for modelled 
PHC interventions, per year, per capita
2030 4·0 2·3 3·5 3·0
Health impact
Total number of deaths averted because 
of PHC (millions)
Total 2020–30 16·2 30·6 13·5 60·1
Gains in life expectancy at birth (years) 2030 compared 
with 2015 baseline
6·7 4·0 2·3 3·7
Because of rounding, numbers might not add up. PHC=primary health care. All numbers are in US$ (2014) unless otherwise indicated. All per-capita numbers are 
population weighted. *Using measure defined as option 5 within Van de Maele and colleagues’ study.3 
Table 3: Investment guide posts for PHC (measure 1), across income groups
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all countries, as few as 16 countries would see a funding 
gap by 2030.
Increasing coverage of PHC interventions in meas-
ure 1 during 2020–30 would avert an estimated 
60·1 million deaths. Inclusion of skilled care at birth 
(ie, measure 2) allows us to report additional maternal 
(1·3 million for measure 1 vs 1·5 million for measure 2 
and measure 3) and neonatal (9·7 million for measure 1 vs 
11·1 million for measure 2 and measure 3) lives saved, 
whereas inclusion of cross-sectoral interventions (ie, 
measure 3) within our model increases the projected 
number of post-neonatal deaths averted (7·7 million for 
measure 1 and measure 2 vs 8·4 million for measure 3; 
table 4). With measure 1, life expectancy would increase by 
an average of 6·7 years in low-income countries, 4·0 years 
in lower-middle-income countries and 2·3 years in upper-
middle-income countries, using population-weighted 
averages (table 3). As well as increasing life expectancy, 
the over all health of the population will also improve, with 
396 million additional healthy years of life during 2020–30 
(figure 3). Most gains from PHC (for measure 1) fall 
within reproductive, maternal, neonatal, and child health. 
About three-quarters of averted stillbirths, neonatal 
deaths, and maternal deaths from PHC interventions are 
estimated to be derived from expanding access to family 
planning, thus reducing unplanned pregnancies and 
related mortality (appendix p 30). Significant gains stand 
to also be made for NCDs. Gains would be even greater 
for measure 2 and measure 3 (data not shown).
Discussion
We have presented a range of measures for PHC 
investment and estimated associated resource needs. 
According to our model, advancing a core set of PHC 
interventions in the health sector (measure 1) would 
require an additional $200 billion per year between 
2020 and 2030 in LMICs. Expanding PHC towards a 
greater scope as outlined in the Declaration of Astana 
(ie, measure 3) would require at least $328 billion per 
year—and probably more.
Explicit intervention-based and input-based operational 
interpretations of PHC can help inform the investment 
agenda in LMICs. Others have previously investigated 
tiered models for PHC expenditure.20 Our approach does 
not imply any successive ordering of interventions 
because many interventions are included under 
measure 2 and measure 3 that bring significant health 
benefits and are highly cost-effective.
Countries might find that one or more measures 
respond more closely to their policy context. During the 
validation process, although country participants ex-
pressed support for having multiple measures, most 
global experts supported measure 1 for universal 
assessment, with the main reason being that measure 1 is 
consistent with the current PHC expenditure methods.3 
This consistency allows a country to establish investment 
costs and to compare this against current expenditure. 
Although measures 2 and 3 are aligned with a broader 
interpretation of PHC in the 21st century,12 the absence of 
agreed methods for reporting expenditure for these 
measures limits such a comparison of projected costs 
and reported current spending. Nevertheless, policy 
should not be limited by what can be measured, and 
forecasted investment needs for the full scope of PHC 
will be essential in all countries. Although our analysis is 
limited by insufficient models for projecting many cross-
sectoral investments in measure 3 that go beyond the 
scope of the original published SDG price tag analysis, 
within the current global programme of work,21 WHO 
is supporting the development of models to address 
additional PHC interventions and cross-sectoral issues to 
broaden future analytical scope.
Figure 1: Additional investment needs for PHC (67 countries)
(A) Measure 1 by year and component. (B) Additional investment needs for three measures of PHC, 
average 2020–30, by component. PHC=primary health care.
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Our estimates for the health SDG targets and for the 
subset of PHC compare in magnitude with global costs 
for other sectors, such as education (SDG 4), with costs 
estimated at 8·5% of GDP for LMICs.22 Although our 
totals, and relative additional per capita needs, give an 
overall impression of what remains to be done, resource 
needs vary across countries, depending on current and 
future health burdens, and the strength and structure of 
health systems. What is clear is that major investments 
need to go into system strengthening, with health work-
force and infrastructure development jointly accounting 
for 53–66% of additional costs within the three PHC 
measures (appendix p 49).
The results provide evidence on likely cost drivers for 
PHC and shed light on the premise of affordability across 
countries. Expanding PHC for all requires an adequate 
workforce that is well motivated, well resourced, and 
available where needed, with accessible infrastructure and 
functioning equipment. We show how health workforces 
need to increase from 5·6 per 1000 population to 6·7 per 
1000 population to support basic functioning PHC 
systems (measure 1). In low-income countries, this would 
require an ambitious four-fold increase from a current 
level of 1·4 health workers per 1000 to 5·9 per 1000. 
Strengthening health systems and scaling up services 
under measure 1 would require on average an additional 
3·3% of GDP for PHC by 2030. In terms of financing, in 
a business-as-usual scenario, projected current health 
expenditure across the 67 countries would increase from 
an average of 6·1% of GDP in 2020 to 6·6% of GDP in 
2030. However, countries with the smallest GDP require 
the largest incremental investments. Even with a 1% GDP 
increased allocation towards PHC, almost 25 countries 
would not reach the modelled benchmarks, which is 
unfortunate because PHC can be a remarkably efficient 
and highly equitable investment.23 Our analysis indicates 
that notable health gains can be achieved by investing in 
PHC, with up to 6·7 years gained in life expectancy in 
just an 11-year timeframe. For an extra $32 per capita, 
these health improvements have substantial value in 
themselves, but will also result in improved economic 
productivity and overall human capital.24 Furthermore, 
research shows that PHC is associated with more 
appropriate, effective, and less costly care.23 Thus, in 
theory, resource savings could potentially arise if countries 
reorient their systems towards PHC (eg, shifting services 
from tertiary or inpatient care to primary level or 
outpatient care). Our model does not take into account 
such shifts, because this kind of contextualised analysis 
would require in-depth country studies.
The impact modelling confirms the catalytic role that 
PHC can play for the UHC and SDG agenda. Most 
interventions within the SDG price tag were classified as 
PHC, which is consistent with Watkins and colleagues,9 
who classified 198 of 218 essential UHC interventions as 
PHC. Almost 75% of the health gain previously estimated 
as part of the SDG agenda10 can be achieved through 
investing in PHC interventions under measure 1, with 
the caveat that many high-burden diseases, such as 
hepatitis, neurological and musculoskeletal disorders, 
and most cancers were not included in the impact 
analysis for the original SDG price tag on which the 
PHC-specific analysis draws. Subsequent work to expand 
the scope has since been done or is ongoing,25 and can be 
incorporated into future updates of PHC resource needs. 
Measures 2 and 3 would bring substantially larger gains. 
However, the current projection model is limited in 
terms of cross-sectoral interventions and does not 
calculate deaths averted from investing in other sectors 
(aside from water and sanitation).
Importantly, even the narrower measure 1 includes 
comprehensive services across disease burden and life 
course needs as relevant to the SDGs; this diff erentiates 
Figure 2: Low-income and middle-income countries with additional financing need even after increasing 
allocation towards primary health care (ie, countries with a gap between primary health care additional 
costs and projected additional finances)
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Trend scenario
1% scenario
2% scenario
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Year
Measure 1 Measure 2 Measure 3 2017 SDG 
price tag 
estimate*
Total deaths averted 60·1 63·4 64·2 89
Proportion of SDG price tag estimate 68% 71% 72% ··
Stillbirths 7·9 9·8 9·8 10·7
Neonatal deaths (0–1 month) 9·7 11·1 11·1 17·8
Post-neonatal deaths (1–59 months) 7·7 7·7 8·4 19·5
Under-5 deaths (neonatal and post-neonatal) 17·5 18·8 19·5 37·3
Maternal deaths 1·3 1·5 1·5 2·0
Deaths from cancer 1·9 1·9 1·9 4·1
Deaths from non-communicable diseases 
(four causes)
11·9 11·9 11·9 14·9
Deaths from tuberculosis 10·6 10·6 10·6 10·6
Deaths from HIV 9·0 9·0 9·0 9·0
Data are millions of deaths averted. Because of rounding, numbers might not add up. PHC=primary health care. 
SDG=Sustainable Development Goal. *Results for years 2020–30 only; the original 2017 analysis presented outcomes 
for 2016–30.
Table 4: Millions of deaths averted through three measures of primary health care; modelled outcomes 
for 67 low-income and middle-income countries, sum 2020–30
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the current service-oriented approach from previous 
models of selective PHC, which made some significant 
health gains, but fell short of the vision of PHC in the 
Declaration of Alma-Ata.
The PHC investment guide posts were derived from a 
specific set of interventions within a pre-existing model,10 
and as such do not cover the full scope of interventions 
defined as PHC across all country contexts. For example, 
the 2017 SDG projections do not include interventions 
for rehabilitative care or long-term home-based care. 
Additionally, common conditions for care seeking in 
LMICs include musculoskeletal complaints and 
endocrine, digestive system, and skin complaints,26 
which are not explicit within our model. WHO is 
engaging in work to create a repository for UHC 
interventions, and this forthcoming work will serve to 
improve standardisation of information on WHO-
recommended interventions, further advancing discus-
sions around PHC. The boundaries within our model 
suggest that our guide posts are conservative estimates. 
Our model generates an average of 5·9 annual outpatient 
visits whereas the reported number of outpatient contacts 
per person per year in EU countries is 7·6.27 Similarly, 
our estimated PHC commodity costs per capita includes 
only a subset of interventions and assumes the use of 
low-cost generic medicines, whereas in reality, budget 
requests for medicines might be much larger. Moreover, 
we have estimated the investment needs from the supply 
side. Once functional capacities are in place, the quality 
of care delivered needs careful attention, including 
clinical effectiveness, comprehensiveness of care, and 
interpersonal quality of care.1,28
Another weakness is our assumption that baselines 
changed little between 2015 and 2019, which might 
underestimate the baseline, and thus overestimate 
incremental resource needs. To address this, during the 
country consultation process we collected the most 
recent data for health infrastructure, health workforce, 
current population service coverage, and other important 
parameters, for inclusion in the model.
Despite the above challenges, the proposed PHC 
measures and investment guide posts are a conceptual 
framework for advancing discussions around invest-
ments in PHC. Global advocates for PHC can add more 
specificity to arguments for investment but in doing so 
should recognise that the guide posts are average 
estimates across countries, and as such should not be 
taken as absolute benchmarks for spending or health 
system maturity at the country level. Country policy 
makers can apply existing models to a locally defined 
PHC package and estimate resource needs. Civil society 
organisations can push for transparent budget allocation 
and benefit packages for PHC. The global community 
should strengthen existing evidence on recurrent and 
capital expenditures on PHC, advocate for targeted donor 
support to countries most in need, and support countries 
to prioritise within limited budgets.
Through our development of PHC investment guide 
posts we present an approach for measuring and 
projecting PHC investment needs in the context of 
advancing the UHC agenda towards the health-related 
SDGs. All countries should identify their own locally 
relevant policies for PHC, establish priority investments 
and associated reforms, and assess the costs and 
budgetary implications of these. In doing so, our approach 
provides a reference. Recommendations for future work 
include expanded models for cross-sectoral analysis, as 
well as projections for a more comprehensive package of 
health services.
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